235 related articles for article (PubMed ID: 29329544)
1. The importance of drug checking outside the context of nightlife in Slovenia.
Sande M; Šabić S
Harm Reduct J; 2018 Jan; 15(1):2. PubMed ID: 29329544
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a drug checking service at a large scale electronic music festival in Portugal.
Valente H; Martins D; Carvalho H; Pires CV; Carvalho MC; Pinto M; Barratt MJ
Int J Drug Policy; 2019 Nov; 73():88-95. PubMed ID: 31398488
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users.
Sande M
Int J Drug Policy; 2016 Jan; 27():65-73. PubMed ID: 25908121
[TBL] [Abstract][Full Text] [Related]
4. Music festival attendees' illicit drug use, knowledge and practices regarding drug content and purity: a cross-sectional survey.
Day N; Criss J; Griffiths B; Gujral SK; John-Leader F; Johnston J; Pit S
Harm Reduct J; 2018 Jan; 15(1):1. PubMed ID: 29304871
[TBL] [Abstract][Full Text] [Related]
5. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
[TBL] [Abstract][Full Text] [Related]
6. Drug checking as a potential strategic overdose response in the fentanyl era.
Laing MK; Tupper KW; Fairbairn N
Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
[TBL] [Abstract][Full Text] [Related]
7. Adulterants and altruism: A qualitative investigation of "drug checkers" in North America.
Palamar JJ; Acosta P; Sutherland R; Shedlin MG; Barratt MJ
Int J Drug Policy; 2019 Dec; 74():160-169. PubMed ID: 31610451
[TBL] [Abstract][Full Text] [Related]
8. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
Gidman W; Coomber R
Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
[TBL] [Abstract][Full Text] [Related]
9. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
[TBL] [Abstract][Full Text] [Related]
10. Pill testing or drug checking in Australia: Acceptability of service design features.
Barratt MJ; Bruno R; Ezard N; Ritter A
Drug Alcohol Rev; 2018 Feb; 37(2):226-236. PubMed ID: 28635057
[TBL] [Abstract][Full Text] [Related]
11. Intentions, actions and outcomes: A follow up survey on harm reduction practices after using an English festival drug checking service.
Measham F; Turnbull G
Int J Drug Policy; 2021 Sep; 95():103270. PubMed ID: 33972157
[TBL] [Abstract][Full Text] [Related]
12. On-site identification of psychoactive drugs by portable Raman spectroscopy during drug-checking service in electronic music events.
Gerace E; Seganti F; Luciano C; Lombardo T; Di Corcia D; Teifel H; Vincenti M; Salomone A
Drug Alcohol Rev; 2019 Jan; 38(1):50-56. PubMed ID: 30614092
[TBL] [Abstract][Full Text] [Related]
13. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
Giné CV; Espinosa IF; Vilamala MV
Drug Test Anal; 2014; 6(7-8):819-24. PubMed ID: 24470121
[TBL] [Abstract][Full Text] [Related]
14. Drug safety testing, disposals and dealing in an English field: Exploring the operational and behavioural outcomes of the UK's first onsite 'drug checking' service.
Measham FC
Int J Drug Policy; 2019 May; 67():102-107. PubMed ID: 30541674
[TBL] [Abstract][Full Text] [Related]
15. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
[TBL] [Abstract][Full Text] [Related]
16. Healthy nightclubs and recreational substance use. From a harm minimisation to a healthy settings approach.
Bellis MA; Hughes K; Lowey H
Addict Behav; 2002; 27(6):1025-35. PubMed ID: 12369470
[TBL] [Abstract][Full Text] [Related]
17. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.
Soussan C; Andersson M; Kjellgren A
Int J Drug Policy; 2018 Feb; 52():71-78. PubMed ID: 29241144
[TBL] [Abstract][Full Text] [Related]
18. Third party drug checking: accessing harm reduction services on the behalf of others.
Larnder A; Burek P; Wallace B; Hore DK
Harm Reduct J; 2021 Sep; 18(1):99. PubMed ID: 34535157
[TBL] [Abstract][Full Text] [Related]
19. The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Portugal's Boom Festival.
Martins D; Barratt MJ; Pires CV; Carvalho H; Vilamala MV; Espinosa IF; Valente H
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28635119
[TBL] [Abstract][Full Text] [Related]
20. Beyond co-production: The construction of drug checking knowledge in a Canadian supervised injection facility.
Betsos A; Valleriani J; Boyd J; McNeil R
Soc Sci Med; 2022 Dec; 314():115229. PubMed ID: 36274456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
